Cempra
Cempra is a pharmaceutical company that researches and develops novel antibacterial therapeutics for the treatment of infectious diseases.
Business Model:
Revenue: $79.3M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Cempra Information
Geographic Data
Address: 6320 Quadrangle Dr
City: Chapel Hill
State: NC
Zip: 27517
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$25M
Raised Total:$108M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cempra is a pharmaceutical company that researches and develops novel antibacterial therapeutics for the treatment of infectious diseases.
Contact Phone:
+19193136601
Contact Email:
Cempra went public on 2/10/2012 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
2/10/2012
Ticker Symbol:
CEMP
Amount Raised:
$50M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2009 | Series C | 6 | $46M |
Ontario Teachers&s; Pension Plan Intersouth Partners I. Wistar Morris III Devon Park BioVentures Quaker BioVentures Aisling Capital Ontario Teachers&s; Pension Plan Intersouth Partners I. Wistar Morris III Devon Park BioVentures Quaker BioVentures Aisling Capital |
4/2006 | Series A | 3 | $22M |
I. Wistar Morris III Intersouth Partners Aisling Capital |
7/2007 | Series B | $0 |
Optimer Pharmaceuticals I. Wistar Morris III Aisling Capital Intersouth Partners Optimer Pharmaceuticals I. Wistar Morris III Aisling Capital Intersouth Partners |
10/2012 | Post-IPO Equity | $25.1M | 8/2011 | Debt Financing | $5M | 2/2012 | IPO | $50.4M |
|
10/2016 | Equity | $10M |
Toyama Chemical |
5/2009 | Equity | $25.5M | 7/2007 | Series B | 4 | $10M |
I. Wistar Morris III Aisling Capital Optimer Pharmaceuticals Intersouth Partners I. Wistar Morris III Aisling Capital Optimer Pharmaceuticals Intersouth Partners |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 8/2017 | Melinta Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
